End-of-life care in heart failure
- 264 Downloads
The clinical syndrome of heart failure is increasing in prevalence, as is the number of elderly persons with heart failure. Increasing frailty and progression of heart failure in large numbers of patients means clinicians are increasingly challenged to provide end-of-life care for heart failure patients. End-of-life care has been little studied, but management can be understood from early clinical trials of advanced heart failure. Evidence-based heart failure medications, including angiotensin-converting enzyme inhibitors and β blockers, improve symptoms in patients with advanced heart failure and depressed ejection fraction and should usually be continued in end-stage disease. Patients also should have ongoing meticulous management of fluid status to maximize quality of life. End-of-life care should be planned with the patient and family and should incorporate comprehensive symptom management, bereavement support, and spiritual support. Ongoing communication with patients and families about prognosis can ease the planning of care when the end of life nears.
KeywordsHeart Failure Palliative Care Left Ventricular Ejection Fraction Continuous Positive Airway Pressure Chronic Heart Failure
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 20.A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group [no authors listed]. J Am Coll Cardiol 1983:755–763.Google Scholar
- 44.Gillian R, Pulchalski CM: Spiritual support in heart failure patients. In Supportive Care in Heart Failure. Edited by Beattie J, Goodlin SJ. New York, NY: Oxford University Press; 2008:299–318.Google Scholar
- 47.Bekelman DB, Sullivan M: Depression and anxiety in patients with chronic heart failure. In Supportive Care in Heart Failure. Edited by Beattie J, Goodlin SJ. New York, NY: Oxford University Press; 2008:273–298.Google Scholar
- 48.Stuart B, Alexander C, Arenella C, et al.; for Standards and Accreditation Committee, Medical Guidelines Task Force: Medical Guidelines for Determining Prognosis in Selected Non-Cancer Diseases. Arlington, VA: National Hospice Organization; 1996.Google Scholar